X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
breast cancer (158) 158
index medicus (149) 149
oncology (143) 143
21-gene recurrence score (139) 139
humans (134) 134
female (130) 130
chemotherapy (110) 110
breast neoplasms - genetics (92) 92
prognosis (86) 86
cancer (75) 75
middle aged (72) 72
breast neoplasms - drug therapy (66) 66
breast neoplasms - pathology (66) 66
women (66) 66
gene-expression (64) 64
tamoxifen (62) 62
adjuvant chemotherapy (59) 59
assay (53) 53
oncotype dx (53) 53
aged (52) 52
adult (51) 51
estrogen-receptor (46) 46
gene expression (43) 43
21-gene assay (41) 41
risk (40) 40
gene expression profiling (37) 37
care and treatment (35) 35
genes (35) 35
medicine & public health (34) 34
genetic aspects (33) 33
neoplasm staging (33) 33
surgery (33) 33
analysis (32) 32
distant recurrence (31) 31
decision-making (30) 30
decision making (29) 29
impact (29) 29
neoplasm recurrence, local - genetics (29) 29
research (29) 29
chemotherapy, adjuvant (28) 28
endocrine therapy (28) 28
biomarkers, tumor - genetics (27) 27
breast neoplasms - diagnosis (27) 27
estrogen (27) 27
recurrence score (27) 27
gene expression profiling - methods (26) 26
receptors, estrogen - metabolism (26) 26
breast neoplasms - metabolism (25) 25
retrospective studies (25) 25
rt-pcr assay (25) 25
therapy (25) 25
patients (24) 24
adjuvant treatment (23) 23
breast neoplasms - therapy (23) 23
diagnosis (23) 23
health aspects (23) 23
cancer therapies (22) 22
international expert consensus (22) 22
tumors (22) 22
cost-effectiveness (21) 21
immunohistochemistry (21) 21
risk factors (21) 21
lymphatic metastasis (20) 20
recurrence (20) 20
article (19) 19
cost-benefit analysis (19) 19
pam50 risk (19) 19
postmenopausal patients (19) 19
prediction (19) 19
predictive value of tests (19) 19
erbb-2 protein (18) 18
late distant recurrence (18) 18
risk assessment (18) 18
clinical trials (17) 17
clinical-practice (17) 17
progesterone-receptor (17) 17
receptors, estrogen - genetics (17) 17
antineoplastic combined chemotherapy protocols - therapeutic use (16) 16
breast neoplasms - chemistry (16) 16
expression (16) 16
genomics (16) 16
medical research (16) 16
treatment outcome (16) 16
aged, 80 and over (15) 15
breast neoplasms - economics (15) 15
validation (15) 15
abridged index medicus (14) 14
biomarkers (14) 14
genetic research (14) 14
hematology, oncology and palliative medicine (14) 14
medical prognosis (14) 14
metastasis (14) 14
neoplasm grading (14) 14
progesterone (14) 14
receptor, erbb-2 - metabolism (14) 14
survival (14) 14
antineoplastic agents - therapeutic use (13) 13
epidermal growth factor (13) 13
gene expression regulation, neoplastic (13) 13
pathology (13) 13
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 02/2012, Volume 118, Issue 3, pp. 788 - 796
BACKGROUND: African American (AA) women experience higher breast cancer mortality than white (W) women. These differences persist even among estrogen receptor... 
disparities | treatment | breast cancer | race | 21‐gene recurrence scores | SURVIVAL | ASSAY | BREAST-CANCER MORTALITY | RECEPTOR | 21-gene recurrence scores | AMERICAN | ONCOLOGY | GENE-EXPRESSION | CARCINOMAS | SOUTHWEST-ONCOLOGY | DISPARITY
Journal Article
BREAST CANCER RESEARCH, ISSN 1465-5411, 10/2019, Volume 21, Issue 1, pp. 1 - 11
Background The benefits of chemotherapy in node-negative, hormone receptor-positive, and human epidermal growth factor receptor 2 (HER2)-negative breast cancer... 
Chemotherapy | IMPACT | ASSAY | 21-gene recurrence score | ONCOTYPE DX | ONCOLOGY | Breast cancer | Survival | EXPRESSION | Epidermal growth factor | Patient outcomes | Mortality | Genes | Adjuvant treatment | Genetic aspects | Epidemiology | Cancer
Journal Article
Journal Article
BMC Cancer, ISSN 1471-2407, 05/2018, Volume 18, Issue 1, pp. 526 - 10
Journal Article
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 10/2015, Volume 153, Issue 3, pp. 573 - 582
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 8/2017, Volume 165, Issue 1, pp. 65 - 76
The 21-gene recurrence score (RS) assay predicts the likelihood of distant recurrence and chemotherapy benefit in early-stage, estrogen receptor (ER)-positive,... 
Mucinous carcinoma | Tubular carcinoma | Medicine & Public Health | Oncology | Solid papillary carcinoma | Breast cancer | Favorable histology | Encapsulated papillary carcinoma | 21-gene recurrence score assay | ASSAY | ONCOTYPE DX | CHEMOTHERAPY | PREDICTION | WOMEN | DECISION-MAKING | ONCOLOGY | INVASIVE TUMOR | GENE-EXPRESSION | IN-SITU | SOLID-PAPILLARY CARCINOMA | Predictive Value of Tests | Carcinoma, Papillary - genetics | Humans | Middle Aged | Transcriptome | Antineoplastic Agents - therapeutic use | Receptors, Estrogen - analysis | Carcinoma, Papillary - secondary | Breast Neoplasms - chemistry | Time Factors | Aged, 80 and over | Adult | Female | Adenocarcinoma, Mucinous - chemistry | Adenocarcinoma, Mucinous - drug therapy | Carcinoma, Papillary - chemistry | Databases, Factual | Precision Medicine | Genetic Predisposition to Disease | Neoplasm Invasiveness | Risk Factors | Carcinoma, Papillary - drug therapy | Gene Expression Profiling - methods | Treatment Outcome | Adenocarcinoma, Mucinous - secondary | Breast Neoplasms - drug therapy | Disease-Free Survival | Phenotype | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Aged | Biomarkers, Tumor - genetics | Adenocarcinoma, Mucinous - genetics | Receptor, ErbB-2 - analysis | Neoplasm Staging | Immunohistochemistry | Chemotherapy | Prognosis | RNA | Oncology, Experimental | Genes | Estrogen | Genetic aspects | Research | Progesterone | Cancer
Journal Article
Cancer, ISSN 0008-543X, 01/2017, Volume 123, Issue 1, pp. 131 - 137
BACKGROUND A 21‐gene expression assay (Oncotype DX recurrence score [RS]) that uses reverse transcriptase‐polymerase chain reaction is used clinically in... 
low risk | 21‐gene expression assay | recurrence score | age | distant metastasis | 21-gene expression assay | ASSAY | CANCER | CHEMOTHERAPY | WOMEN | IMPACT | DECISION-MAKING | ONCOLOGY | RECOMMENDATIONS | GENE-EXPRESSION | END-POINTS | ASSOCIATION | Lymph Nodes - pathology | Prognosis | Follow-Up Studies | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Receptors, Progesterone - genetics | Neoplasm Recurrence, Local - pathology | Young Adult | Neoplasm Metastasis - drug therapy | Antineoplastic Agents, Hormonal - therapeutic use | Aged, 80 and over | Adult | Female | Receptors, Estrogen - genetics | Gene Expression Profiling - methods | Breast Neoplasms - drug therapy | Neoplasm Metastasis - genetics | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Chemotherapy, Adjuvant - methods | Neoplasm Metastasis - pathology | Tamoxifen - therapeutic use | Neoplasm Recurrence, Local - genetics | Aged | Care and treatment | Diagnosis | Research | Breast diseases | Gene expression | Lymphatic system | RNA-directed DNA polymerase | Identification methods | Estrogens | Estrogen receptors | Data processing | Breast cancer | Metastasis | Tamoxifen | Cancer therapies | Patients | ErbB-2 protein | Lymph nodes | Metastases | Polymerase chain reaction | Breast carcinoma | Chemotherapy | Epidermal growth factor | Breast | Cancer | Lymph
Journal Article
The American Journal of Surgery, ISSN 0002-9610, 10/2018, Volume 216, Issue 4, pp. 689 - 693
American Society for Radiation Oncology (ASTRO) suitability criteria for accelerated partial breast irradiation (APBI) and the 21-gene recurrence score (RS)... 
Intraoperative radiation therapy | ASTRO suitability criteria for APBI | Breast cancer | 21-Gene recurrence score | Recurrences | SURGERY | ASSAY | TAMOXIFEN | OLDER | TRIAL | IRRADIATION | ONCOLOGY | RADIOTHERAPY | CONSENSUS STATEMENT | Carcinoma, Ductal, Breast - genetics | Breast Neoplasms - surgery | Prognosis | Follow-Up Studies | Humans | Middle Aged | Neoplasm Recurrence, Local - mortality | Carcinoma, Ductal, Breast - mortality | Aged, 80 and over | Adult | Female | Retrospective Studies | Radiotherapy, Adjuvant | Mastectomy, Segmental - methods | Carcinoma, Ductal, Breast - surgery | Neoplasm Recurrence, Local - prevention & control | Risk Assessment | Brachytherapy - methods | Decision Support Techniques | Neoplasm Recurrence, Local - diagnosis | Clinical Decision-Making - methods | Breast Neoplasms - radiotherapy | Breast Neoplasms - genetics | Intraoperative Care - methods | Carcinoma, Ductal, Breast - radiotherapy | Survival Analysis | Breast Neoplasms - mortality | Neoplasm Recurrence, Local - genetics | Aged | Biomarkers, Tumor - genetics | Care and treatment | Anopheles | Radioisotope brachytherapy | Genes | Radiation | Genetic research | Genetic aspects | Research institutes | Health aspects | Histochemistry | Cancer | Task forces | Demography | Estrogens | Clinical trials | Endocrine therapy | Data processing | Radiation therapy | Criteria | Cancer therapies | Patients | Noncompliance | Studies | Demographics | Chemotherapy | Histopathology | Mastectomy | Breast | Irradiation | Background radiation | Age | Tumors
Journal Article
Annals of Oncology, ISSN 0923-7534, 05/2018, Volume 29, Issue 5, pp. 1280 - 1285
Abstract Background The 21-gene recurrence score (RS) (Oncotype DX®; Genomic Health, Redwood City, CA) partitions hormone receptor positive, node negative... 
Recurrence | Pathological assessment | 21-gene assay | Prognosis | Early breast cancer | early breast cancer | recurrence | Original articles | prognosis | pathological assessment
Journal Article